Sergey Shlyapnikov

439 total citations
8 papers, 306 citations indexed

About

Sergey Shlyapnikov is a scholar working on Infectious Diseases, Surgery and Clinical Biochemistry. According to data from OpenAlex, Sergey Shlyapnikov has authored 8 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Surgery and 2 papers in Clinical Biochemistry. Recurrent topics in Sergey Shlyapnikov's work include Antimicrobial Resistance in Staphylococcus (3 papers), Bacterial Identification and Susceptibility Testing (2 papers) and Streptococcal Infections and Treatments (2 papers). Sergey Shlyapnikov is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (3 papers), Bacterial Identification and Susceptibility Testing (2 papers) and Streptococcal Infections and Treatments (2 papers). Sergey Shlyapnikov collaborates with scholars based in Russia, Singapore and United Kingdom. Sergey Shlyapnikov's co-authors include Albertus Beishuizen, Ricard Ferrer, Juan González del Castillo, Stefan Krueger, Jennifer Townsend, Eric H. Gluck, Jens‐Ulrik Stæhr Jensen, Giulio Toccafondi, G. Gavazzi and M. Broyles and has published in prestigious journals such as Critical Care Medicine, Infection Control and Hospital Epidemiology and Clinical Chemistry and Laboratory Medicine (CCLM).

In The Last Decade

Sergey Shlyapnikov

8 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sergey Shlyapnikov Russia 5 173 79 43 42 41 8 306
Romaric Larcher France 12 158 0.9× 73 0.9× 50 1.2× 19 0.5× 68 1.7× 44 428
Ramon Sager Switzerland 2 150 0.9× 66 0.8× 33 0.8× 11 0.3× 39 1.0× 3 225
Alba León Colombia 10 157 0.9× 59 0.7× 35 0.8× 47 1.1× 80 2.0× 34 280
Claire Shappell United States 12 157 0.9× 53 0.7× 59 1.4× 16 0.4× 38 0.9× 22 308
Laurent Chow‐Chine France 11 189 1.1× 92 1.2× 34 0.8× 18 0.4× 96 2.3× 36 424
Matthieu Legrand France 7 162 0.9× 41 0.5× 23 0.5× 24 0.6× 17 0.4× 12 319
Sandra H. Hoeboer Netherlands 6 236 1.4× 77 1.0× 80 1.9× 23 0.5× 101 2.5× 6 373
Sara Cajander Sweden 10 172 1.0× 66 0.8× 25 0.6× 91 2.2× 38 0.9× 26 363
Yasumasa Kawano Japan 10 227 1.3× 66 0.8× 69 1.6× 44 1.0× 66 1.6× 21 322
Graham Jeffers United Kingdom 11 255 1.5× 39 0.5× 86 2.0× 76 1.8× 18 0.4× 13 408

Countries citing papers authored by Sergey Shlyapnikov

Since Specialization
Citations

This map shows the geographic impact of Sergey Shlyapnikov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergey Shlyapnikov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergey Shlyapnikov more than expected).

Fields of papers citing papers by Sergey Shlyapnikov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergey Shlyapnikov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergey Shlyapnikov. The network helps show where Sergey Shlyapnikov may publish in the future.

Co-authorship network of co-authors of Sergey Shlyapnikov

This figure shows the co-authorship network connecting the top 25 collaborators of Sergey Shlyapnikov. A scholar is included among the top collaborators of Sergey Shlyapnikov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergey Shlyapnikov. Sergey Shlyapnikov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Zasowski, Evan J, Trang D Trinh, Kimberly C. Claeys, et al.. (2022). International Validation of a Methicillin-Resistant Staphylococcus aureus Risk Assessment Tool for Skin and Soft Tissue Infections. Infectious Diseases and Therapy. 11(6). 2253–2263. 6 indexed citations
2.
Batyrshin, Ildar, et al.. (2020). Staged approach in the treatment of patients with enterocutaneous fistulae. Pirogov Russian Journal of Surgery. 66–66. 3 indexed citations
3.
Schüetz, Philipp, Albertus Beishuizen, M. Broyles, et al.. (2019). Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Clinical Chemistry and Laboratory Medicine (CCLM). 57(9). 1308–1318. 184 indexed citations
4.
Shlyapnikov, Sergey, et al.. (2018). Real-Life Evidence for Tedizolid Phosphate in the Treatment of Cellulitis and Wound Infections: A Case Series. Infectious Diseases and Therapy. 7(3). 387–399. 5 indexed citations
5.
Zasowski, Evan J, Trang D Trinh, Kimberly C. Claeys, et al.. (2018). 289. International Validation of a Methicillin-Resistant Staphylococcus aureus (MRSA) Risk Assessment Tool for Acute Bacterial Skin and Skin Structure Infections (ABSSSI). Open Forum Infectious Diseases. 5(suppl_1). S118–S119. 1 indexed citations
6.
Shlyapnikov, Sergey, et al.. (2017). APPLICATION OF NEGATIVE PRESSURE WOUND THERAPY IN THE TREATMENT OF PYOINFLAMMATORY COMPLICATIONS AFTER SPINAL SURGERY. Russian Journal of Spine Surgery (Khirurgiya Pozvonochnika). 14(1). 78–84. 4 indexed citations
7.
Проценко, Д. Н., et al.. (2011). C1-esterase inhibitor infusion increases survival rates for patients with sepsis*. Critical Care Medicine. 40(3). 770–777. 85 indexed citations
8.
Brown, Samuel M., et al.. (2007). Prospective Surveillance for Surgical Site Infection in St. Petersburg, Russian Federation. Infection Control and Hospital Epidemiology. 28(3). 319–325. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026